Progress in Clinical, Pharmacological, Chemical and Structural Biological Studies of Huperzine A: A Drug of Traditional Chinese Medicine Origin for the Treatment of Alzheimers Disease

HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of...

Full description

Saved in:
Bibliographic Details
Published inCurrent medicinal chemistry Vol. 10; no. 21; pp. 2231 - 2252
Main Authors JIANG, Hualiang, LUO, Xiaomin, BAI, Donglu
Format Journal Article
LanguageEnglish
Published Oak Park, IL Bentham Science Publishers Ltd 01.11.2003
Bentham Science Publishers
Bentham Science
Subjects
Online AccessGet full text
ISSN0929-8673
1875-533X
DOI10.2174/0929867033456747

Cover

Abstract HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of investigations by an ever-increasing number of researchers since 1980s. In the last four years, HupA has been further studied in many aspects such as the chemical synthesis, structural modification, structureactivity relationship, various biological effects, and mechanisms of action. A number of papers dealing with the computational modeling and X-ray crystallographic studies of HupA-AChE complex have also been published. This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.
AbstractList HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of investigations by an ever-increasing number of researchers since 1980's. In the last four years, HupA has been further studied in many aspects such as the chemical synthesis, structural modification, structure-activity relationship, various biological effects, and mechanisms of action. A number of papers dealing with the computational modeling and X-ray crystallographic studies of HupA-AChE complex have also been published. This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.
HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of investigations by an ever-increasing number of researchers since 1980s. In the last four years, HupA has been further studied in many aspects such as the chemical synthesis, structural modification, structureactivity relationship, various biological effects, and mechanisms of action. A number of papers dealing with the computational modeling and X-ray crystallographic studies of HupA-AChE complex have also been published. This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.
HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of investigations by an ever-increasing number of researchers since 1980's. In the last four years, HupA has been further studied in many aspects such as the chemical synthesis, structural modification, structure-activity relationship, various biological effects, and mechanisms of action. A number of papers dealing with the computational modeling and X-ray crystallographic studies of HupA-AChE complex have also been published. This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of investigations by an ever-increasing number of researchers since 1980's. In the last four years, HupA has been further studied in many aspects such as the chemical synthesis, structural modification, structure-activity relationship, various biological effects, and mechanisms of action. A number of papers dealing with the computational modeling and X-ray crystallographic studies of HupA-AChE complex have also been published. This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.
Author Hualiang Jiang
Xiaomin Luo
Donglu Bai
Author_xml – sequence: 1
  givenname: Hualiang
  surname: JIANG
  fullname: JIANG, Hualiang
  organization: 1 Drug Discovery and Design Center and
– sequence: 2
  givenname: Xiaomin
  surname: LUO
  fullname: LUO, Xiaomin
  organization: 1 Drug Discovery and Design Center and
– sequence: 3
  givenname: Donglu
  surname: BAI
  fullname: BAI, Donglu
  email: dlbai@mail.shcnc.ac.cn
  organization: 2 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15163464$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/14529340$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAQhiNURD_gzglZSHBiwY7tJOa2bIEiFbWCBVVcLK8z2bhN7GA7LPTOb-Lv4Wj7IfUAJ4_feV7PyDP72Y51FrLsMcEvc1KyV1jkoipKTCnjRcnKe9keqUo-45Se7WR7U3qW8nQ32w_hHGOSC4wfZLuE8VxQhveyP6ferT2EgIxFi85Yo1X3Ap22yvdKu86tt8KihX6KkLI1-hz9qOPo0_WNuWaSOtYGAnINOhoH8JfGApq_RnN06Mf1JC-9qk00ziZ60aZ0APQRaqMn8sSbdeqhcR7FFhILKvZg42Scd5ctmB58QIcmgArwMLvfqC7Ao6vzIPvy7u1ycTQ7Pnn_YTE_nq04K-OsynFV1CtBcUF0kzeAMRdU1TUTVKi8IVyzRmiOiVZQY1YLITAvkliRmqmGHmTPt-8O3n0fIUTZm6Ch65QFNwZZ8pIzWuH_gqTkgle0SODTO-C5G336kiBzwrEoCM0T9OQKGlc91HLwplf-l7weXAKeXQEqpM9vvLLahFuOk4KygiUObzntXQgemlsEy2mH5N0dSpbijkWbqKaxRa9M9y_jbGs0IcLPm0LKX8i0gyWXnwou2RGh-OvymzxL_O8tv0pjblUftAGr4cbYxjjIzWYjYfRwkYbegY5Su166AezouxTbmLxyaAe5BushFYtGdyBNCPa6Qyp_uG7sYeo86SOk_mUY1DoFOSX0LzsdC90
CitedBy_id crossref_primary_10_1016_j_bse_2008_05_006
crossref_primary_10_1016_j_biopha_2024_117652
crossref_primary_10_1159_000085382
crossref_primary_10_2217_14796708_2_4_379
crossref_primary_10_1016_j_biopha_2018_06_147
crossref_primary_10_1007_s00253_020_10560_9
crossref_primary_10_1038_aps_2013_7
crossref_primary_10_1007_s12264_019_00425_1
crossref_primary_10_1038_aps_2009_91
crossref_primary_10_1007_s12088_024_01361_z
crossref_primary_10_3389_fphar_2016_00227
crossref_primary_10_1016_j_tet_2011_01_047
crossref_primary_10_1021_jo300872y
crossref_primary_10_1002_ange_201302268
crossref_primary_10_1016_j_cbi_2008_04_033
crossref_primary_10_1517_17460441_3_1_65
crossref_primary_10_1002_psc_682
crossref_primary_10_18632_aging_204336
crossref_primary_10_1016_j_ejphar_2004_07_027
crossref_primary_10_1016_j_cbi_2005_10_031
crossref_primary_10_1039_D3CS00282A
crossref_primary_10_1021_ja903868n
crossref_primary_10_1016_j_phytochem_2018_11_019
crossref_primary_10_1002_ange_201208571
crossref_primary_10_4155_bio_2022_0045
crossref_primary_10_1016_j_tet_2009_06_006
crossref_primary_10_3390_jof9121134
crossref_primary_10_1016_j_jep_2007_05_030
crossref_primary_10_1016_j_phytochem_2008_04_017
crossref_primary_10_1021_ol902389e
crossref_primary_10_1021_ja101893b
crossref_primary_10_1016_j_jpba_2007_02_019
crossref_primary_10_3987_COM_08_S_D_48
crossref_primary_10_1080_14786419_2012_708660
crossref_primary_10_1002_hlca_200490178
crossref_primary_10_1007_s11274_014_1737_6
crossref_primary_10_1142_S0192415X12500474
crossref_primary_10_1351_pac200779040469
crossref_primary_10_1007_s11356_023_25800_4
crossref_primary_10_1016_j_bmcl_2004_11_060
crossref_primary_10_1155_2014_642128
crossref_primary_10_1002_anie_201208571
crossref_primary_10_13005_bpj_1588
crossref_primary_10_3390_i8111165
crossref_primary_10_1016_j_tjog_2011_04_004
crossref_primary_10_1021_acs_jnatprod_0c01195
crossref_primary_10_1155_2013_608430
crossref_primary_10_1111_j_1365_2672_2010_04777_x
crossref_primary_10_1002_prot_24216
crossref_primary_10_1002_bdd_686
crossref_primary_10_1016_j_ejphar_2019_172851
crossref_primary_10_1021_acs_jmedchem_0c01863
crossref_primary_10_1016_j_ejmech_2009_10_039
crossref_primary_10_1098_rstb_2007_2025
crossref_primary_10_1080_00032719_2020_1821700
crossref_primary_10_1038_nchembio0908_515
crossref_primary_10_1080_14786419_2018_1434648
crossref_primary_10_1016_j_ijpharm_2006_12_029
crossref_primary_10_1155_2022_7697863
crossref_primary_10_3390_molecules181214670
crossref_primary_10_1007_s10529_020_02836_x
crossref_primary_10_1016_j_chroma_2004_10_097
crossref_primary_10_1016_j_fitote_2024_106220
crossref_primary_10_1038_s41598_019_52481_2
crossref_primary_10_1186_s12866_022_02605_y
crossref_primary_10_1038_aps_2017_28
crossref_primary_10_1016_j_bmc_2010_05_071
crossref_primary_10_1016_j_tetlet_2005_11_037
crossref_primary_10_3109_03639045_2011_625031
crossref_primary_10_1080_00498254_2019_1623935
crossref_primary_10_1208_s12249_019_1513_x
crossref_primary_10_1007_s11240_015_0856_6
crossref_primary_10_1007_s11655_019_3178_4
crossref_primary_10_1007_s10571_007_9163_z
crossref_primary_10_1002_elan_201900507
crossref_primary_10_1007_s11274_010_0476_6
crossref_primary_10_3390_ph6081039
crossref_primary_10_1002_anie_201302268
crossref_primary_10_1039_b402985m
crossref_primary_10_1002_jhet_5570450605
crossref_primary_10_1016_j_ijpharm_2008_01_007
crossref_primary_10_1016_j_ejmech_2011_09_051
crossref_primary_10_1016_j_ejmech_2013_09_050
crossref_primary_10_1007_s10529_025_03562_y
crossref_primary_10_2174_1570159X17666191101125530
ContentType Journal Article
Copyright 2003 INIST-CNRS
Copyright © 2003 Bentham Science Publishers
Copyright_xml – notice: 2003 INIST-CNRS
– notice: Copyright © 2003 Bentham Science Publishers
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7T5
7TM
7U9
7X7
7XB
88E
88I
8AO
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
BGLVJ
C1K
CCPQU
D1I
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
M0S
M1P
M2P
M7N
PDBOC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7TK
7X8
DOI 10.2174/0929867033456747
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Technology Collection (ProQuest)
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database (Proquest)
ProQuest Health & Medical Collection
Medical Database
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
Materials Science Collection
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Materials Science Collection
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList Neurosciences Abstracts

MEDLINE - Academic
ProQuest Central Student
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1875-533X
EndPage 2252
ExternalDocumentID 1007628281
14529340
15163464
10_2174_0929867033456747
ark_67375_R65_4H130VTZ_X
http_www_eurekaselect_com_openurl_content_php_genre_article_issn_09298673_volume_10_issue_21_spage_2231
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
.5.
0R~
29F
36B
3V.
4.4
53G
5GY
69Q
7X7
88E
88I
8AO
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
AAEGP
AAVXF
ABEEF
ABJCF
ABJNI
ABUWG
ABVDF
ACGFS
ACGOD
ACITR
ACIWK
ACPRK
ADBBV
AENEX
AFKRA
AFRAH
AFUQM
AGJNZ
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ANTIV
AZQEC
BENPR
BGLVJ
BPHCQ
BVXVI
C1A
CCPQU
CS3
D1I
DU5
DWQXO
EBS
EJD
F5P
FYUFA
GH2
GNUQQ
HCIFZ
HMCUK
HZ~
IPNFZ
KB.
KCGFV
KFI
LK5
M1P
M2P
M7R
O9-
P2P
PDBOC
PQQKQ
PROAC
PSQYO
Q2X
RIG
UKHRP
ABMOS
ACZAY
AEUYN
AFHZU
AGQPQ
BSCLL
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PUEGO
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7TM
7U9
7XB
8FK
C1K
H94
K9.
M7N
PKEHL
PQEST
PQUKI
PRINS
Q9U
7TK
7X8
ID FETCH-LOGICAL-b547t-82086db93061cf2fe00593add4939a2f15c4f9c501caed04d999056c4f81d4af3
IEDL.DBID BENPR
ISSN 0929-8673
IngestDate Thu Sep 04 16:38:29 EDT 2025
Fri Sep 05 11:36:17 EDT 2025
Mon Oct 06 18:37:17 EDT 2025
Thu Jan 02 23:01:09 EST 2025
Wed Apr 02 07:23:14 EDT 2025
Wed Oct 01 02:32:22 EDT 2025
Thu Apr 24 23:07:39 EDT 2025
Thu Aug 28 11:50:23 EDT 2025
Tue Aug 27 15:42:25 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 21
Keywords Nitrogen heterocycle
Psychotropic
Memory
Active site
Molecular interaction
Esterases
Review
Acetylcholinesterase
Modeling
Learning
Alkaloid
Structure activity relation
Molecular model
Anticholinesterase agent
Chemical synthesis
CNS stimulant
Enzyme
Enzyme inhibitor
Inhibitor enzyme complex
Neuroprotective agent
Carboxylic ester hydrolases
Toxin
Biological fixation
Nootropic agent
Neurotoxin
Hydrolases
Antidote
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b547t-82086db93061cf2fe00593add4939a2f15c4f9c501caed04d999056c4f81d4af3
Notes istex:A9F3A594ACC265D375E275E569A492BBFDCC4D82
ark:/67375/R65-4H130VTZ-X
ArticleID:CMC-10-21-2231
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
PMID 14529340
PQID 215096132
PQPubID 44100
PageCount 22
ParticipantIDs proquest_miscellaneous_75754380
proquest_miscellaneous_17595836
proquest_journals_215096132
pubmed_primary_14529340
pascalfrancis_primary_15163464
crossref_primary_10_2174_0929867033456747
crossref_citationtrail_10_2174_0929867033456747
istex_primary_ark_67375_R65_4H130VTZ_X
benthamscience_primary_http_www_eurekaselect_com_openurl_content_php_genre_article_issn_09298673_volume_10_issue_21_spage_2231
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-11-01
PublicationDateYYYYMMDD 2003-11-01
PublicationDate_xml – month: 11
  year: 2003
  text: 2003-11-01
  day: 01
PublicationDecade 2000
PublicationPlace Oak Park, IL
PublicationPlace_xml – name: Oak Park, IL
– name: United Arab Emirates
– name: Schiphol
PublicationTitle Current medicinal chemistry
PublicationTitleAlternate CMC
PublicationYear 2003
Publisher Bentham Science Publishers Ltd
Bentham Science Publishers
Bentham Science
Publisher_xml – name: Bentham Science Publishers Ltd
– name: Bentham Science Publishers
– name: Bentham Science
SSID ssj0012900
Score 2.0791152
SecondaryResourceType review_article
Snippet HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life....
SourceID proquest
pubmed
pascalfrancis
crossref
istex
benthamscience
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2231
SubjectTerms Acetylcholinesterase
Alkaloids
Alzheimer's disease
Animals
Biological and medical sciences
Biological effects
Clinical Trials as Topic
Crystallography, X-Ray
Documentation
Herbal medicine
Humans
Huperzine A
Medical sciences
Models, Molecular
Molecular modeling
Molecular Structure
Neuropharmacology
Neuroprotective Agents - chemistry
Neuroprotective Agents - pharmacology
Neuroprotective Agents - therapeutic use
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Sesquiterpenes - chemistry
Sesquiterpenes - pharmacology
Sesquiterpenes - therapeutic use
Structure-Activity Relationship
X-Ray crystallography
Title Progress in Clinical, Pharmacological, Chemical and Structural Biological Studies of Huperzine A: A Drug of Traditional Chinese Medicine Origin for the Treatment of Alzheimers Disease
URI http://www.eurekaselect.com/openurl/content.php?genre=article&issn=09298673&volume=10&issue=21&spage=2231
https://api.istex.fr/ark:/67375/R65-4H130VTZ-X/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/14529340
https://www.proquest.com/docview/215096132
https://www.proquest.com/docview/17595836
https://www.proquest.com/docview/75754380
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1875-533X
  dateEnd: 20081231
  omitProxy: true
  ssIdentifier: ssj0012900
  issn: 0929-8673
  databaseCode: 7X7
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1875-533X
  dateEnd: 20081231
  omitProxy: true
  ssIdentifier: ssj0012900
  issn: 0929-8673
  databaseCode: BENPR
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Technology Collection
  customDbUrl:
  eissn: 1875-533X
  dateEnd: 20081231
  omitProxy: true
  ssIdentifier: ssj0012900
  issn: 0929-8673
  databaseCode: 8FG
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/technologycollection1
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bj9JAFJ7sQqI-aBRvdRXnwWBMtqHtTFswMQZ3F4kJK1nZDfFlMm2nQpYFpEvi-uDv8ud5zswUxARfeJie0qY9l296Lh8hr_wwC5I8x7LBVoYbFOXKNErA4nOmIo6NIdjv3D-Neuf80ygc7ZF-2QuDZZWlT9SOOpun-I28CaEJ2UlY8H7x3UXSKEyulgwa0jIrZO_0hLF9Ug1wMFaFVD-cnA7O1mmFoG16UgATuK0oZiZviai8iWuw5DEGkCJGtpW7Cbj9sbyyoWgrcFXxHfzAQkpZwLPMDQnGbpSqo1X3PrlnYSbtGL14QPbUrEZuH5XsbjVyq2-T6jXSGJjx1TeHdLjpxioOaYMONoOtbx6S3wMs5gLXSCczageKTg__FjIL5RACKmcZ_aIH1OJwD2p4L_URW75I5zntrRZqiTOuaect7dDj5eobLkMQzSbmQyVFkm9VKFreM_2s6bwoAG4KABZkbbU8ntiZ_hyryZVavi7osUk_PSLn3ZPhUc-1zA9uEvL42gVY0oqypA37GT_Ng1xp5kFwxbzN2jLI_TDleTsNPT-VKvN4BjAXkBwsAvzmMmePSWU2n6mnhDKfxZwHMg4k4zJTCWxAVSgzP_eiTHqeQ35tv2exMGM-dMOTAH0UarVUl7LQvEQCdFJYYjOB3QTIhbwYL4Q2d2HNXaADF1almDCBRsB-SxuTCHyhw4UAbOY7pFnqlUjtXHakB5miPKqm-Fc1HfJmfUZ5s7tlG1pV14JyeYm1fHEozqJQ8B5gmIvhVzFySH1Llzf_HAJk5xF3yEGp3ML6uUKsrdIhL9dHQZMx6yRnar4qBODTdthi0W6JGLYMSHzgkCfGZjbXxrIAxr1n_732AbljSizxw9hzUgG9Vi8AKl4ndbIfj2L4bXU_1q0z-APQwm3W
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVqIcQFBeptDuAYqQatX2ru0YqUKhaZXSJkQlRRWXZW2vadQ0CXEjKAd-Fxf-GzO764QglVuv6_FD2tmZbzyPj5DnfpgHaVFg2WAtxwBFuTKLUjjxBVMRx8YQ7HdutaPmMX93Ep4skN9VLwyWVVY2URvqfJjhP_ItcE3ITsKCN6OvLpJGYXK1YtCQllkh39YTxmxfx4G6_AYRXLm934DtfhEEe7vdnaZrSQbcNOTxhQsesBblaQLQ2c-KoFCa5A5OPU9YIoPCDzNeJFno-ZlUucdzQFQAGmARkB6XBYPn3iBLnPEEYr-lt7vtztE0jREkpgcGMIhbi2Jm8qQYBWzhGix5jAGEiZHd5XYKbuZUnlvXN-col3DPv2Phpixh7wpDunE1Ktbece8uuWNhLa0bPbxHFtRghSzvVGxyK-RmyybxV8hGx4zLvtyk3Vn3V7lJN2hnNkj78j751cHiMTDFtDegdoBpf_NvIbNQDT2gcpDTD3ogLg4ToYZnU1-x5ZJ0WNDmZKTGOFOb1l_TOm2MJ19wGZx23jM_RimSiqtS0eqb6XtNH0YB4FMAzCBrq_Pxxnr_x6nqnavxy5I2TLrrATm-FiV4SBYHw4F6TCjzWcx5IONAMi5zlULAq0KZ-4UX5dLzHPJzfp_FyIwV0Q1WAvRfqMlYnclS8yAJOAPCEqkJ7F5A7uXR6Uho8yKseRHoMIRVKSaMYxMQ3-nDKwJfaPckAAv6Dtmq9Epkdg480pH0UR5VU_yrmg55Nb2j-tirZTe0qk4F5fgMawfjUBxFoeBNwEwfu5_EiUPW5nR59uQQQgQecYesVsotrF0txdQKOGR9ehU0GbNccqCGk1IAHk7CGouuloghREGiBYc8Mmdm9m4sQ2Dce_Lfd6-T5Wa3dSgO99sHq-SWKe_En3JPySLouHoGMPUiXbPGgJLP121__gDye6jT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progress+in+Clinical%2C+Pharmacological%2C+Chemical+and+Structural+Biological+Studies+of+Huperzine+A%3A+A+Drug+of+Traditional+Chinese+Medicine+Origin+for+the+Treatment+of+Alzheimer%27s+Disease&rft.jtitle=Current+medicinal+chemistry&rft.au=Jiang%2C+Hualiang&rft.au=Luo%2C+Xiaomin&rft.au=Bai%2C+Donglu&rft.date=2003-11-01&rft.issn=0929-8673&rft.volume=10&rft.issue=21&rft.spage=2231&rft.epage=2252&rft_id=info:doi/10.2174%2F0929867033456747&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0929-8673&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0929-8673&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0929-8673&client=summon